Apellis appoints Jim Chopas as VP, Corporate Controller and CAO

Apellis Pharmaceuticals, Inc.

Jim Chopas named VP, Corporate Controller and principal accounting officer, effective August 30, 2021.
Annual base salary of $315,000; target bonus 30% of base; one-time sign-on bonus of $50,000.
Granted option for 21,750 shares and RSU for 7,600 shares, both vesting over four years.
Previously served as VP, principal financial and accounting officer and treasurer at Radius Health.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jim Chopas

Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer

APLS · Apellis Pharmaceuticals, Inc.

Effective: 2021-08-30
Filed: August 30, 2021, 7:59 PM ET

On August 24, 2021, the Board of Directors (the “Board”) of Apellis Pharmaceuticals, Inc. (the “Company”) appointed Jim Chopas, as Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer of the Company, effective as of August 30, 2021 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jim Chopas was appointed as Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer at Apellis Pharmaceuticals, Inc..

Action: appointed
Role: Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer

Exact text from the filing

On August 24, 2021, the Board of Directors (the “Board”) of Apellis Pharmaceuticals, Inc. (the “Company”) appointed Jim Chopas, as Vice President, Corporate Controller / Chief Accounting Officer and principal accounting officer of the Company, effective as of August 30, 2021 (the “Effective Date”).

View on SEC.gov

Apellis Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-259951

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.